New Jersey ACEP is committed to serving our communities and promoting rapid access to buprenorphine and other appropriate treatments for patients struggling with opioid use disorder. NJ ACEP recognizes the increasing mortality from opioid overdose and supports buprenorphine initiation in the emergency department for the treatment of opioid use disorder. We strongly encourage all emergency departments in New Jersey to integrate buprenorphine into their patient treatment options. We will work to promote buprenorphine education, mentorship, and transition of care for all emergency physicians in the state.
Coming Soon...virtual MAT Waiver Courses
Tuesday, May 11th from 10 am- 2 pm
Thursday, June 10th from 5 pm- 9 pm
Wednesday, July 21st from 9 am- 1pm
Tuesday, October 5th from 5 pm-9 pm
Tuesday, June 15th from 10 am – 11:30 am
Thursday, September 9th from 8 pm-9:30 pm